Scholarlink

<p>Alzheimer’s disease is the most prominent neurological illness, and the present investigation sets out to determine the impact of bioactive substances from endophytic fungi on acetylcholinesterase (AChE) inhibition. Medicinal plant <i>Withania somnifera</i> (L.) Dunal was used to isolate endophytic fungi, and WSE42 (out of 49 isolates) exhibited higher AChE inhibition (78.57%) and free radical scavenging activity (82.47%) in its methanolic crude extract. WSE42 was identified as <i>Curvularia pseudobrachyspora</i> (accession number-PP837926), and among all the fractions collected by column chromatography, two fractions (F3 and F4) exhibited potential for AChE inhibition with IC<sub>50</sub> of 17.99&#xa0;µg/ml and 19.91&#xa0;µg/ml, respectively. These two fractions were found to show IC<sub>50</sub> values in the range of 36–44&#xa0;µg/ml for antioxidant potential. Structural elucidation studies revealed the compound to be 2,3-dihydrowithaferin A (F3) and withanolide Z (F4). Thus, this study ascertained the potential of withanolides as AChE inhibitors and antioxidant molecules that can play a key role in the management of Alzheimer’s disease.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Acetylcholinesterase inhibiting withanolides from Curvularia pseudobrachyspora, an endophytic fungus of Withania somnifera (L.) Dunal

  • 期刊论文

  • 发表日期：

    2026年7月16日

查看全文
  • Anu Gupta,
  • M. Vasundhara

摘要

Alzheimer’s disease is the most prominent neurological illness, and the present investigation sets out to determine the impact of bioactive substances from endophytic fungi on acetylcholinesterase (AChE) inhibition. Medicinal plant Withania somnifera (L.) Dunal was used to isolate endophytic fungi, and WSE42 (out of 49 isolates) exhibited higher AChE inhibition (78.57%) and free radical scavenging activity (82.47%) in its methanolic crude extract. WSE42 was identified as Curvularia pseudobrachyspora (accession number-PP837926), and among all the fractions collected by column chromatography, two fractions (F3 and F4) exhibited potential for AChE inhibition with IC50 of 17.99 µg/ml and 19.91 µg/ml, respectively. These two fractions were found to show IC50 values in the range of 36–44 µg/ml for antioxidant potential. Structural elucidation studies revealed the compound to be 2,3-dihydrowithaferin A (F3) and withanolide Z (F4). Thus, this study ascertained the potential of withanolides as AChE inhibitors and antioxidant molecules that can play a key role in the management of Alzheimer’s disease.